§ Contact·Editorial
Editorial correspondence.
Corrections, citation queries, and source suggestions are welcome. Clinical questions and sales inquiries are not.
What we welcome
Corrections to factual errors on this site. If a citation is misattributed, a dose is misstated, a year is wrong, or a study finding is summarized inaccurately, write and tell us. Include the page URL, the specific passage, and the corrected source. We will revise.
Citation queries. If a numbered reference does not match the claim it is attached to, or if a DOI does not resolve, let us know.
Source suggestions. If a peer-reviewed publication on CJC-1295 — including any future Phase 2 or 3 publication that may someday appear — is missing from our references, send the citation. We prefer PubMed-indexed primary literature, ClinicalTrials.gov registry updates, and official FDA or WADA regulatory documents.
What we cannot respond to
Clinical questions. We do not provide medical advice. We do not recommend dosing schedules, treatment protocols, or stacks. We do not have clinicians on staff and we do not refer to any. If you have clinical questions, consult a licensed clinician.
Sales inquiries. We do not sell CJC-1295 or any other peptide. We have nothing to sell and no vendors to refer.
Protocol coaching, dosing schedules, or personalized recommendations. We do not provide them in any form.
Contact form
The form below collects editorial correspondence only. Submissions are received by email. We do not store submissions in any database, share them with third parties, or use them for any commercial purpose. Allow several days for a reply; we read every submission but cannot guarantee a response to every message.
Disclaimer
Nothing on this site, including any reply you may receive from us, constitutes medical advice. CJC-1295 is not approved for any human indication and is not legally prescribable in the United States. This site does not sell any product and is not affiliated with any vendor or manufacturer.